CDK8/19 inhibitors for therapy of advanced prostate cancer
Ended Project Grant Awarded Last action
- Award ID
- R44CA203184
- Recipient
-
Senex Biotechnology Inc. UEI G8XKMW3DYMQ6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,977,275
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Columbia, SC 29208, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $846,340 | |
| Original award | $1,130,935 |
Quick answers
Who received award R44CA203184?
R44CA203184 was awarded to Senex Biotechnology Inc. by National Cancer Institute (National Institutes of Health) on May 13, 2020.
How much is award R44CA203184 worth?
$1,977,275 has been obligated on R44CA203184.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award